Use of prophylactic phototherapy for RhD neonatal disease in a referral service

J Pediatr (Rio J). 2023 Jan-Feb;99(1):53-58. doi: 10.1016/j.jped.2022.04.004. Epub 2022 Jun 23.

Abstract

Objective: This study aimed to describe the effect of prophylactic phototherapy in the treatment of infants with Neonatal Hemolytic Disease.

Method: A retrospective cohort study was carried out with 199 RhD-positive infants, born to RhD-negative mothers, alloimmunized for RhD antigen, between January 2009 and December 2018.

Results: The incidence of exchange transfusions in the study population was 9.5%, with a mean maximum bilirubin value of 11.3 mg % (± 4.3mg %). Bilirubin's maximum peak was achieved with a mean of 119.2 life hours (± 70.6h).

Conclusion: The low incidence of exchange transfusion, the extended maximum bilirubin peak for later ages, and the low mean of the maximum bilirubin values may indicate a positive effect of prophylactic phototherapy in the treatment of this disease. Further studies must be carried out to confirm these findings.

Keywords: Hemolytic disease of the newborn; Neonatal hyperbilirubinemia; Phototherapy; Rh isoimmunization.

MeSH terms

  • Bilirubin
  • Erythroblastosis, Fetal* / prevention & control
  • Female
  • Humans
  • Hyperbilirubinemia, Neonatal* / etiology
  • Hyperbilirubinemia, Neonatal* / prevention & control
  • Infant
  • Infant, Newborn
  • Mothers
  • Phototherapy / adverse effects
  • Retrospective Studies

Substances

  • Bilirubin